Maynard Um
-
-
-
-
-
-
-
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatm
-
-
-
-
-
-
-
Ladenburg Thalmann Upgrades enVVeno Medical Corp (NVNO) to Buy
-
-
-
-
-
-
-
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
-
-
-
-
-
-
-
enVVeno receives unfavorable FDA appeal decision for VenoValve device
-
-
-
-
-
-
-
Ladenburg Thalmann Downgrades enVVeno Medical Corp (NVNO) to Neutral
-
-
-
-
-
-
-
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
-
-
-
-
-
-
-
Three-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular Surgery
-
473,862 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


